1. Home
  2. NIE vs TECX Comparison

NIE vs TECX Comparison

Compare NIE & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virtus Equity & Convertible Income Fund of Beneficial Interest

NIE

Virtus Equity & Convertible Income Fund of Beneficial Interest

SELL

Current Price

$25.38

Market Cap

726.3M

Sector

Finance

ML Signal

SELL

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$20.96

Market Cap

618.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
NIE
TECX
Founded
2007
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
726.3M
618.9M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
NIE
TECX
Price
$25.38
$20.96
Analyst Decision
Strong Buy
Analyst Count
0
10
Target Price
N/A
★ $71.00
AVG Volume (30 Days)
90.5K
★ 232.9K
Earning Date
01-01-0001
11-05-2026
Dividend Yield
★ 9.04%
N/A
EPS Growth
N/A
★ 40.70
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$22.78
$15.60
52 Week High
$27.24
$39.53

Technical Indicators

Market Signals
Indicator
NIE
TECX
Relative Strength Index (RSI) 48.48 27.01
Support Level $25.28 $20.52
Resistance Level $25.76 $30.80
Average True Range (ATR) 0.35 1.23
MACD 0.09 0.07
Stochastic Oscillator 65.22 12.66

Price Performance

Historical Comparison
NIE
TECX

About NIE Virtus Equity & Convertible Income Fund of Beneficial Interest

Virtus AllianzGI Equity & Convertible Income Fund is a diversified, closed-end management investment company. The investment objective is to provide total return through a combination of current income, current gains and long-term capital appreciation. The fund pursues its objective by investing in a diversified portfolio of equity securities and income-producing convertible securities. Its portfolio of investments comprises different sector investments, such as aerospace and defense, banks, IT services, software, and others.

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

Share on Social Networks: